Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Lymphoma, also known as malignant lymphoma, is a general term for a group of malignant tumors originating from the lymphopoietic system. It is one of the most common tumors in China. In 2020, there were 544,352 new cases of non-Hodgkin lymphoma (NHL) worldwide, ranking 13th among all new cases of malignancies.

Video-assisted lobectomies performed withpowered staplers resulted in nearly half as many patient bleeding complicationsas those conducted with manual staplers, according to a recent study. Patients treated with powered staplers wererelease

CerTest Biotec (Zaragoza, Spain), a biotechnologycompany focused on the development and manufacturing of IVD diagnosticproducts, has opened a new facility in Spain for the research, development andmanufacture of molecular diagnostics produc

RainbowGenomics said recently that it is partnering with Color to provide hereditary cancer and heart health genetic risk assessment testsin Hong Kong. Rainbow, a preferred partner of Color in Hong Kong, willoffer that firms genetic tests f

Grail has raised $300 million in a Series C financing round that wasoversubscribed, according to the firm.Ally Bridge Group led the round alongwith Hillhouse Capital Group and 6 Dimensions Capital. Blue Pool Capital, ChinaMerchant Securitie

Freenome has initiated a clinical study tohelp bring an AI-Genomics blood test for colorectal cancer to the U.S. market. Freenome is looking to build a diagnostictest that can learn from its mistakes. The South San Francisco, CA- basedcompa